ARCHIVES

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Varmus Discusses Grant Policy, Changes in Congress and Ebola

December 12, 2014

Anil Potti Joins Myrtle Beach Private Practice.

June 3, 2011

FDA Issues Final Regs for Mammography Facilities, Personnel

November 7, 1997

In Brief: Byrd Heads ACS, Lee Clark President-Elect; NCI Needs Community Medical Oncologist

November 7, 1975

Other News: ESAs Fail To Reduce Blood Transfusions, SEER Data Show

November 20, 2009